Published in Eur J Radiol on July 05, 2009
How I treat POEMS syndrome. Blood (2012) 1.71
Castleman's disease--a two compartment model of HHV8 infection. Nat Rev Clin Oncol (2010) 0.95
Unicentric mixed variant Castleman disease associated with Hashimoto disease: the role of PET/CT in staging and evaluating response to the treatment. Cancer Imaging (2011) 0.89
Markedly elevated serum total N-terminal propeptide of type I collagen is a novel marker for the diagnosis and follow up of patients with POEMS syndrome. Haematologica (2014) 0.87
Computed tomography assessment of bone lesions in patients with POEMS syndrome. Eur Radiol (2014) 0.85
Multimodal imaging and clinical characteristics of bone lesions in POEMS syndrome. Int J Clin Exp Med (2015) 0.83
Two more cases of evaluation of POEMS syndrome using 18-FDG PET/CT. Eur J Radiol (2010) 0.82
Polyneuropathy as Novel Initial Manifestation in a Case of "Nonsecretory" POEMS Syndrome with Sjögren's Syndrome. Case Rep Med (2017) 0.75
A special subtype of POEMS syndrome: IgG4 subtype. Am J Transl Res (2016) 0.75
Osteolytic-variant POEMS syndrome: an uncommon presentation of "osteosclerotic" myeloma. Skeletal Radiol (2017) 0.75
Role of translocation in the activation and function of protein kinase B. J Biol Chem (1997) 7.29
Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell (1991) 5.98
The PINHEAD/ZWILLE gene acts pleiotropically in Arabidopsis development and has overlapping functions with the ARGONAUTE1 gene. Development (1999) 3.98
The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet (1997) 3.70
p70s6k function is essential for G1 progression. Nature (1993) 2.91
Regulation of actin microfilament integrity in living nonmuscle cells by the cAMP-dependent protein kinase and the myosin light chain kinase. J Cell Biol (1988) 2.72
The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells. J Cell Biol (1998) 2.50
Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol (1998) 2.17
Intrapleural talc for the prevention of recurrent pneumothorax. Chest (1994) 2.15
Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice. J Natl Cancer Inst (2001) 2.10
Nuclear localization of p85s6k: functional requirement for entry into S phase. EMBO J (1994) 2.06
Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw. Osteoporos Int (2012) 2.01
Genetic heterogeneity of angiogenesis in mice. FASEB J (2000) 1.98
Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell Mol Life Sci (2001) 1.89
Microinjection of p34cdc2 kinase induces marked changes in cell shape, cytoskeletal organization, and chromatin structure in mammalian fibroblasts. Cell (1990) 1.82
Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest (2000) 1.77
Regulation of transcription factor localization: fine-tuning of gene expression. Trends Biochem Sci (1996) 1.76
Simplified method for the estimation of inorganic phosphorus in body fluids. Clin Chem (1966) 1.62
Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei. J Immunol (1995) 1.59
Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals. Cell (1990) 1.59
Deadly diving? Physiological and behavioural management of decompression stress in diving mammals. Proc Biol Sci (2011) 1.57
Effects of tactile-kinesthetic stimulation in preterms: a controlled trial. Indian Pediatr (2001) 1.57
Activation of p34cdc2 protein kinase by microinjection of human cdc25C into mammalian cells. Requirement for prior phosphorylation of cdc25C by p34cdc2 on sites phosphorylated at mitosis. J Biol Chem (1994) 1.53
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol (2001) 1.53
RhoA GTPase and serum response factor control selectively the expression of MyoD without affecting Myf5 in mouse myoblasts. Mol Biol Cell (1998) 1.51
Clinical and serologic follow-up in patients with neuroborreliosis. Neurology (1998) 1.50
[Eagle syndrome and carotid dissection]. Neurologia (2010) 1.47
Differential methylation and altered conformation of cytoplasmic and nuclear forms of protein phosphatase 2A during cell cycle progression. J Cell Biol (1995) 1.46
Treatment of hemobilia with selective hepatic artery embolization. J Vasc Interv Radiol (1996) 1.45
Repair of congenital sternal cleft in infants and adolescents. Ann Thorac Surg (1998) 1.45
Nausea, vomiting, and abdominal pain after Roux-en-Y anastomosis: motility of the jejunal limb. Gastroenterology (1985) 1.42
Exchange transfusions in neonatal sepsis. Indian Pediatr (1991) 1.41
Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity. Clin Nephrol (2008) 1.40
Under-recognized renal insufficiency in hospitalized patients: implications for care. Eur J Intern Med (2010) 1.38
Inhibition of cAMP-dependent protein kinase plays a key role in the induction of mitosis and nuclear envelope breakdown in mammalian cells. EMBO J (1991) 1.38
[Geriatric information in the hospital discharge reports of patients over 65 years of age admitted to an Internal Medicine Department]. Rev Clin Esp (2004) 1.38
Demonstration in living cells of an intragenic negative regulatory element within the rodent c-fos gene. Cell (1990) 1.35
Vimentin dephosphorylation by protein phosphatase 2A is modulated by the targeting subunit B55. Mol Biol Cell (1999) 1.35
The two guanine nucleotide exchange factor domains of Trio link the Rac1 and the RhoA pathways in vivo. Oncogene (1998) 1.33
Serum response factor p67SRF is expressed and required during myogenic differentiation of both mouse C2 and rat L6 muscle cell lines. J Cell Biol (1992) 1.30
Cell cycle oscillation of phosphatase inhibitor-2 in rat fibroblasts coincident with p34cdc2 restriction. Nature (1990) 1.29
Cloning and characterization of AKAP 95, a nuclear protein that associates with the regulatory subunit of type II cAMP-dependent protein kinase. J Biol Chem (1994) 1.29
Modulation of vimentin containing intermediate filament distribution and phosphorylation in living fibroblasts by the cAMP-dependent protein kinase. J Cell Biol (1989) 1.28
p67SRF is a constitutive nuclear protein implicated in the modulation of genes required throughout the G1 period. Cell Regul (1991) 1.28
cdc25 is a nuclear protein expressed constitutively throughout the cell cycle in nontransformed mammalian cells. J Cell Biol (1992) 1.27
Molecular cloning, chromosomal localization, and cell cycle-dependent subcellular distribution of the A-kinase anchoring protein, AKAP95. Exp Cell Res (1998) 1.25
cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol Cell Biol (1999) 1.24
Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J Rheumatol (1990) 1.21
Protein kinase B beta/Akt2 plays a specific role in muscle differentiation. J Biol Chem (2000) 1.21
The role of intergenerational discrepancy of cultural orientation in drug use among Latina adolescents. Subst Use Misuse (1998) 1.20
Human pulmonary dirofilariasis: analysis of 24 cases from São Paulo, Brazil. Chest (1997) 1.20
Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts. Mol Biol Cell (1996) 1.20
IgE cross-reactivity between Ascaris and domestic mite allergens: the role of tropomyosin and the nematode polyprotein ABA-1. Allergy (2009) 1.17
Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J Cell Sci (1997) 1.17
Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol (1995) 1.17
Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford) (2005) 1.15
ras-induced c-fos expression and proliferation in living rat fibroblasts involves C-kinase activation and the serum response element pathway. EMBO J (1990) 1.14
An optical coherence microscope for 3-dimensional imaging in developmental biology. Opt Express (2000) 1.11
Posttraumatic stress disorder as a risk factor for obesity among male military veterans. Acta Psychiatr Scand (2007) 1.11
Psychiatric disorders of abused women at a shelter. Psychiatr Q (1990) 1.11
Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+. Oncogene (1996) 1.11
Casein kinase II induces c-fos expression via the serum response element pathway and p67SRF phosphorylation in living fibroblasts. EMBO J (1991) 1.08
Age patterns in the prevalence of DSM-IV depressive/anxiety disorders with and without physical co-morbidity. Psychol Med (2008) 1.07
Intestinal brush border membrane Na+/glucose cotransporter functions in situ as a homotetramer. Proc Natl Acad Sci U S A (1990) 1.06
The serum response factor nuclear localization signal: general implications for cyclic AMP-dependent protein kinase activity in control of nuclear translocation. Mol Cell Biol (1995) 1.04
Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells. Exp Cell Res (2000) 1.04
Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients. Brain (1996) 1.03
The retinoblastoma-like protein p130 is involved in the determination of reserve cells in differentiating myoblasts. Curr Biol (2000) 1.03
An improved method for determination of serum albumin and globulin. Clin Chem (1966) 1.02
Expression and purification of the DNA-binding domain of SRF: SRF-DB, a part of a DNA-binding protein which can act as a dominant negative mutant in vivo. Exp Cell Res (1993) 1.02
Transcription-terminating mutation in telethonin causing autosomal recessive muscular dystrophy type 2G in a European patient. Neuromuscul Disord (2008) 1.02
Research on factors allowing a risk assessment of spore-forming pathogenic bacteria in cooked chilled foods containing vegetables: a FAIR collaborative project. Int J Food Microbiol (2000) 1.01
Flavobacterium ceti sp. nov., isolated from beaked whales (Ziphius cavirostris). Int J Syst Evol Microbiol (2007) 1.00
Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. J Natl Cancer Inst (2001) 1.00
Aggressive conservative treatment of esophageal perforations in children. J Pediatr Surg (2003) 1.00
Online magnetic bead dynamic protein-affinity selection coupled to LC-MS for the screening of pharmacologically active compounds. Anal Chem (2009) 0.99
Cell cycle-dependent stimulation of the HIV-1 promoter by Tat-associated CAK activator. Virology (2000) 0.99
Bcl-2 inhibits p53 nuclear import following DNA damage. Oncogene (1997) 0.97
Aplasia cutis congenita with dystrophic epidermolysis bullosa: clinical and mutational study. Br J Dermatol (2014) 0.96
Two nuclear localization signals present in the basic-helix 1 domains of MyoD promote its active nuclear translocation and can function independently. Proc Natl Acad Sci U S A (1995) 0.96
Deregulation of translational control of the 65-kDa regulatory subunit (PR65 alpha) of protein phosphatase 2A leads to multinucleated cells. J Biol Chem (1995) 0.96
Oil application in preterm babies--a source of warmth and nutrition. Indian Pediatr (1987) 0.96
Changing environmental context does not reliably affect memory. Mem Cognit (1985) 0.95
Delayed cyclin A and B1 degradation in non-transformed mammalian cells. J Cell Sci (1995) 0.94
TGF-beta 1 and cAMP attenuate cyclin A gene transcription via a cAMP responsive element through independent pathways. Oncogene (1995) 0.94
Measurement of general health status in obstructive sleep apnea hypopnea patients. Sleep (1995) 0.93
Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. Am J Hypertens (1998) 0.93
Probabilistic view of the transformation of cultured C3H/10T1/2 mouse embryo fibroblasts by 3-methylcholanthrene. Proc Natl Acad Sci U S A (1980) 0.92
Development of non-pyramidal neurons in the rat sensorymotor cortex during the fetal and early postnatal periods. J Hirnforsch (1981) 0.92
[Impact of infertility and assisted reproductive techniques on sexuality]. Gynecol Obstet Fertil (2008) 0.92
Intravenous metronidazole for the treatment of Clostridium difficile colitis. Dis Colon Rectum (2001) 0.91
Nuclear import of the myogenic factor MyoD requires cAMP-dependent protein kinase activity but not the direct phosphorylation of MyoD. J Cell Sci (1994) 0.91
The populations and quality improvement seminar for medical residents. Acad Med (2000) 0.91
Influence of baking enzymes on antimicrobial activity of five bacteriocin-like inhibitory substances produced by lactic acid bacteria isolated from Lithuanian sourdoughs. Lett Appl Microbiol (2008) 0.90
Ras signaling in tumor necrosis factor-induced apoptosis. EMBO J (1996) 0.90
Polyarteritis nodosa associated with idiopathic pulmonary fibrosis: report of two cases. Ann Rheum Dis (1989) 0.89
A putative human male infertility gene DAZLA: genomic structure and methylation status. Mol Hum Reprod (1997) 0.89
Descending necrotizing mediastinitis: a retrospective surgical experience. Eur J Cardiothorac Surg (1999) 0.89
Cortical organization for receptive language functions in Chinese, English, and Spanish: a cross-linguistic MEG study. Neuropsychologia (2004) 0.89
Pelvic arteriovenous malformation as a rare cause of sciatica. Br J Rheumatol (1997) 0.88